{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:14:54Z","timestamp":1777364094582,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bcmd.2017.05.007","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T11:32:28Z","timestamp":1494675148000},"page":"51-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Dysfunctional fibrinolysis and cerebral venous thrombosis"],"prefix":"10.1016","volume":"65","author":[{"given":"Aniket","family":"Prabhudesai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrimati","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanjaksha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bipin","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2017.05.007_bb0005","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1161\/STROKEAHA.112.671453","article-title":"The incidence of cerebral venous thrombosis: a cross-sectional study","volume":"43","author":"Coutinho","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0010","doi-asserted-by":"crossref","first-page":"210676","DOI":"10.1155\/2012\/210676","article-title":"Cerebral venous thrombosis misdiagnosed and mismanaged","volume":"2012","author":"Sasidharan","year":"2012","journal-title":"Thrombosis"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0015","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","article-title":"Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Saposnik","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0020","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/MBC.0b013e32835fad1e","article-title":"Hereditary thrombophilia in cerebral venous thrombosis: a study from India","volume":"24","author":"Pai","year":"2013","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/STROKEAHA.116.015294","article-title":"Venous thrombotic recurrence after cerebral venous thrombosis: a long-term follow-up study","volume":"48","author":"Palazzo","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0030","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood-2004-08-3253","article-title":"Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis","volume":"105","author":"Lisman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0035","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1055\/s-0037-1615105","article-title":"The 4G\/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism","volume":"79","author":"Stegnar","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2017.05.007_bb0040","article-title":"Cerebral venous thrombosis: a Tunisian monocenter study on 160 patients","author":"Sassi","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.bcmd.2017.05.007_bb0045","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/01.wnl.0000297195.97325.a8","article-title":"Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis","volume":"70","author":"Wysokinska","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0050","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood-2003-02-0443","article-title":"Hyperhomocysteinemia in cerebral vein thrombosis","volume":"102","author":"Martinelli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0055","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1177\/0300060516664807","article-title":"Clinical associations, biological risk factors and outcomes of cerebral venous sinus thrombosis","volume":"44","author":"Gunes","year":"2016","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.bcmd.2017.05.007_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.10.001","article-title":"Cerebral venous thrombosis: analysis of a multicenter cohort from the United States","volume":"17","author":"Wasay","year":"2008","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.bcmd.2017.05.007_bb0065","first-page":"178","article-title":"Cerebral venous-sinus thrombosis: a case series analysis","volume":"36","author":"Ashjazadeh","year":"2011","journal-title":"Iran J. Med. Sci."},{"issue":"10","key":"10.1016\/j.bcmd.2017.05.007_bb0070","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1161\/STROKEAHA.107.512814","article-title":"Cerebral venous thrombosis: a descriptive multicenter study of patients in Pakistan and Middle East","volume":"39","author":"Khealani","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0075","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/01.CIR.0000087598.05977.45","article-title":"Cerebral venous thrombosis in children: a multifactorial origin","volume":"108","author":"Heller","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0080","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1182\/blood-2005-09-3578","article-title":"Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis","volume":"107","author":"Dentali","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0085","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.STR.29.9.1765","article-title":"Prothrombin gene G20210\u2192a transition is a risk factor for cerebral venous thrombosis","volume":"29","author":"Reuner","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/107602960100700214","article-title":"Venous thromboembolism in young patients from western India: a study","volume":"7","author":"Ghosh","year":"2001","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.bcmd.2017.05.007_bb0095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/beha.1999.0034","article-title":"Fibrinolysis and thrombosis","volume":"12","author":"Booth","year":"1999","journal-title":"Baillieres Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.bcmd.2017.05.007_bb0100","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/archinte.1991.00400090023006","article-title":"A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism","volume":"151","author":"Prins","year":"1991","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcmd.2017.05.007_bb0105","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/bjh.13911","article-title":"Prolonged clot lysis time increases the risk of a first but not recurrent venous thrombosis","volume":"172","author":"Karasu","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.05.007_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1642556","article-title":"Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states","volume":"59","author":"Kruithof","year":"1988","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2017.05.007_bb0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/labmed\/lmw023","article-title":"A case of unexplained cerebral sinus thrombosis in a 22-year-old obese Caucasian woman","volume":"47","author":"Seheult","year":"2016","journal-title":"Lab. Med."},{"key":"10.1016\/j.bcmd.2017.05.007_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-217361","article-title":"PAI-1 polymorphism as a cause of severe high altitude associated arteriovenous thrombosis","author":"Nair","year":"2016","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.bcmd.2017.05.007_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","article-title":"Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1","volume":"116","author":"Meltzer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF02334612","article-title":"Deep cerebral venous thrombosis and hereditary tissue plasminogen activator (t-PA) deficiency","volume":"15","author":"Tezzon","year":"1994","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.bcmd.2017.05.007_bb0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/01.STR.22.3.401","article-title":"Cerebral venous thrombosis with plasminogen deficiency","volume":"22","author":"Schutta","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.bcmd.2017.05.007_bb0140","first-page":"178","article-title":"Decreased plasma fibrinolytic potential as a risk for venous and arterial thrombosis","volume":"43","author":"Lisman","year":"2017","journal-title":"Semin. Thromb. Hemost."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961730058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961730058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:32:44Z","timestamp":1761049964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107997961730058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":28,"alternative-id":["S107997961730058X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.05.007","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysfunctional fibrinolysis and cerebral venous thrombosis","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}